Trial intelligence / Profile preview

Lidocaine and ropivacaine combination for infraclavicular brachial plexus block

2023-510028-63-00Phase 4Completed

Sponsor
Nordsjællands Hospital
Start
Mar 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine and lidocaine + epinephrine in perioperative pain (2 arms), sponsored by Nordsjællands Hospital. Primary endpoint: Total time to breakthrough pain. Started Mar 2024; status: completed.

02

Drugs

ropivacainelidocaine + epinephrine
03

Conditions

perioperative pain

Beyond the preview

Go deeper on 2023-510028-63-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-510028-63-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call